{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:46:54Z","timestamp":1792676814784,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.sapharm.2024.04.010","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T05:14:51Z","timestamp":1714972491000},"page":"689-696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The role of community pharmacy in the promotion of continence care: A systematic review"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7486-2322","authenticated-orcid":false,"given":"Alan","family":"Uren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoba","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Cotterill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ade","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2024.04.010_bib1","series-title":"Excellence in Continence Care: Practical Guidance for Commissioners, and Leaders in Health and Social Care","year":"2018"},{"issue":"4","key":"10.1016\/j.sapharm.2024.04.010_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1742-1241.2008.01974.x","article-title":"Prevalence of urinary and faecal incontinence and nocturnal enuresis and attitudes to treatment and help-seeking amongst a community-based representative sample of adults in the United Kingdom","volume":"63","author":"Buckley","year":"2009","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.010_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.eururo.2013.08.031","article-title":"Global prevalence and economic burden of urgency urinary incontinence: a systematic review","volume":"65","author":"Milsom","year":"2014","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.sapharm.2024.04.010_bib4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/0193945909354903","article-title":"Experiencing and managing urinary incontinence: a qualitative study","volume":"32","author":"Hayder","year":"2010","journal-title":"West J Nurs Res"},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.010_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eururo.2011.07.049","article-title":"Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States","volume":"61","author":"Coyne","year":"2012","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.sapharm.2024.04.010_bib6","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/j.1365-2702.2007.01787.x","article-title":"The meaning of women's experience of living with long-term urinary incontinence is powerlessness","volume":"16","author":"H\u00e4gglund","year":"2007","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.sapharm.2024.04.010_bib7","series-title":"Incontinence: Proceedings of the Sixth International Consultation on Incontinence","first-page":"2427","article-title":"Primary prevention, continence promotion, models of care and education","author":"Newman","year":"2017"},{"issue":"70\u201372","key":"10.1016\/j.sapharm.2024.04.010_bib8","article-title":"Formalising pharmacy's role in continence management","volume":"88","author":"Vowles","year":"2007","journal-title":"Aust J Pharm"},{"key":"10.1016\/j.sapharm.2024.04.010_bib9","unstructured":"Dumoulin C, Adewuyi T, Booth J, Bradley C, Burgio K, Hagen S. Adult conservative management. In: Abrams P, Cardozo L, Wagg A, Wein A, editors. Incontinence: Proceedings of the Sixth International Consultation on Incontinence, Tokyo Sixth. Plymouth: Health Publications Limited; p. 1443\u20131628."},{"key":"10.1016\/j.sapharm.2024.04.010_bib10","series-title":"Faecal Incontinence in Adults: Management NICE Guideline CG49","year":"2007"},{"key":"10.1016\/j.sapharm.2024.04.010_bib11","series-title":"Initial Assessment and Investigation of Urinary Incontinence","year":"2013"},{"key":"10.1016\/j.sapharm.2024.04.010_bib12","series-title":"Cost-Effective Commissioning for Continence Care","year":"2015"},{"issue":"4","key":"10.1016\/j.sapharm.2024.04.010_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/1715163519852378","article-title":"Case finding for urinary incontinence and falls in older adults at community pharmacies","volume":"152","author":"Duong","year":"2019","journal-title":"Can Pharm J"},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.010_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/ijpp.12161","article-title":"Chronic obstructive pulmonary disease case finding by community pharmacists: a potential cost-effective public health intervention","volume":"23","author":"Wright","year":"2015","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.sapharm.2024.04.010_bib15","series-title":"The Community Pharmacy Contractual Framework for 2019\/20-2023\/24: Supporting Delivery for the NHS Long Term Plan","author":"England","year":"2019"},{"issue":"8","key":"10.1016\/j.sapharm.2024.04.010_bib16","first-page":"35","article-title":"Pharmacists' role in managing male urinary incontinence","volume":"40","author":"Rattu","year":"2015","journal-title":"US Pharm"},{"key":"10.1016\/j.sapharm.2024.04.010_bib17","unstructured":"General Pharmaceutical Services in England 2015\/16 - 2020\/21. NHSBSA. https:\/\/www.nhsbsa.nhs.uk\/statistical-collections\/general-pharmaceutical-services-england\/general-pharmaceutical-services-england-201516-202021. Accessed 10\/March\/2023.."},{"issue":"8","key":"10.1016\/j.sapharm.2024.04.010_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005764","article-title":"The positive pharmacy care law: an area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England","volume":"4","author":"Todd","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2024.04.010_bib19","article-title":"Community pharmacy explained","author":"Baird","year":"2020","journal-title":"The King\u2019s Fund"},{"key":"10.1016\/j.sapharm.2024.04.010_bib21","unstructured":"Report: how has the COVID-19 pandemic affected people's experiences of bladder and bowel services? Healthwatch Bristol. https:\/\/www.healthwatchbristol.co.uk\/report\/2022-04-06\/report-how-has-covid-19-pandemic-affected-peoples-experiences-bladder-and-bowel. Accessed 10\/March\/2023."},{"issue":"3","key":"10.1016\/j.sapharm.2024.04.010_bib22","article-title":"Community pharmacies: an ideal setting to promote continence","volume":"11","author":"Gordon","year":"2005","journal-title":"Aust. N Z Contin J"},{"issue":"5","key":"10.1016\/j.sapharm.2024.04.010_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1715163515597242","article-title":"A pharmacist's guide to care of adult patients presenting with lower urinary tract symptoms","volume":"148","author":"Gabriel","year":"2015","journal-title":"Can Pharm J"},{"key":"10.1016\/j.sapharm.2024.04.010_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0897190004263216","article-title":"Current management of urinary incontinence","volume":"17","author":"Knight-Klimas","year":"2004","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.sapharm.2024.04.010_bib25","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.sapharm.2024.04.010_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/nau.20041","article-title":"ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence","volume":"23","author":"Avery","year":"2004","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"10.1016\/j.sapharm.2024.04.010_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.socscimed.2004.12.001","article-title":"Storylines of research in diffusion of innovation: a meta-narrative approach to systematic review","volume":"61","author":"Greenhalgh","year":"2005","journal-title":"Soc Sci Med"},{"issue":"4","key":"10.1016\/j.sapharm.2024.04.010_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/EFI-180221","article-title":"The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers","volume":"34","author":"Hong","year":"2018","journal-title":"EFI"},{"key":"10.1016\/j.sapharm.2024.04.010_bib29","author":"Calder"},{"key":"10.1016\/j.sapharm.2024.04.010_bib30","article-title":"Feasibility of a community pharmacist intervention for lower urinary tract symptoms","author":"Duong","year":"2023","journal-title":"Curr Under Rev"},{"key":"10.1016\/j.sapharm.2024.04.010_bib31","article-title":"Expectations and perceptions of Dutch pharmacy staff regarding a new framework for continence care: a focus group study","volume":"14","author":"Schreuder","year":"2021","journal-title":"Health Serv Insights"},{"issue":"12","key":"10.1016\/j.sapharm.2024.04.010_bib32","article-title":"Community pharmacy interventions for health promotion: effects on professional practice and health outcomes","volume":"2019","author":"Steed","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.sapharm.2024.04.010_bib33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.sapharm.2016.06.010","article-title":"Attitudes and attributes of pharmacists in relation to practice change - a scoping review and discussion","volume":"13","author":"Luetsch","year":"2017","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2024.04.010_bib34","series-title":"Pharmacy: A Way Forward for Public Health","author":"Root","year":"2017"},{"key":"10.1016\/j.sapharm.2024.04.010_bib35","unstructured":"Public Health Service Community Pharmacy Scotland. https:\/\/www.cps.scot\/core-2\/public-health-service. Accessed 10\/March\/2023.."},{"key":"10.1016\/j.sapharm.2024.04.010_bib36","unstructured":"PGEU Position Paper on the Lessons learned from the COVID-19 pandemic PGEU. https:\/\/www.pgeu.eu\/publications\/pgeu-position-paper-on-the-lessons-learned-from-the-covid-19-pandemic\/. Accessed 12\/May\/2023.."},{"issue":"8","key":"10.1016\/j.sapharm.2024.04.010_bib37","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1016\/j.sapharm.2021.12.003","article-title":"Pharmacy interventions on COVID-19 in Europe: mapping current practices and a scoping review","volume":"18","author":"Costa","year":"2022","journal-title":"Res Soc Adm Pharm"},{"issue":"6","key":"10.1016\/j.sapharm.2024.04.010_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-050043","article-title":"Rapid realist review of the role of community pharmacy in the public health response to COVID-19","volume":"11","author":"Maidment","year":"2021","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.sapharm.2024.04.010_bib39","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.sapharm.2017.06.001","article-title":"Application of the Consolidated Framework for Implementation Research to community pharmacy: a framework for implementation research on pharmacy services","volume":"13","author":"Shoemaker","year":"2017","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2024.04.010_bib40","series-title":"New Medicine Service (NMS)","year":"2020"},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.010_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13012-019-0867-5","article-title":"Factors influencing national implementation of innovations within community pharmacy: a systematic review applying the Consolidated Framework for Implementation Research","volume":"14","author":"Weir","year":"2019","journal-title":"Implement Sci"},{"key":"10.1016\/j.sapharm.2024.04.010_bib42","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1186\/1471-2458-11-582","article-title":"Public health in community pharmacy: a systematic review of pharmacist and consumer views","volume":"11","author":"Eades","year":"2011","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.sapharm.2024.04.010_bib43","article-title":"Pharmacists should have read-write access to health records, standards body says","author":"Burns","year":"2022","journal-title":"Pharmaceut J"},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.010_bib44","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.18549\/PharmPract.2020.1.1870","article-title":"Primary health care policy and vision for community pharmacy and pharmacists in England","volume":"18","author":"Anderson","year":"2020","journal-title":"Pharm Pract (Granada."},{"issue":"2","key":"10.1016\/j.sapharm.2024.04.010_bib45","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.sapharm.2016.04.009","article-title":"Disruptive innovation in community pharmacy \u2013 impact of automation on the pharmacist workforce","volume":"13","author":"Spinks","year":"2017","journal-title":"Res Soc Adm Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2024.04.010_bib46","first-page":"S57","article-title":"Feasibility of a community pharmacist intervention for lower urinary tract symptoms","volume":"150","author":"Sadowski","year":"2017","journal-title":"Can Pharm J"},{"issue":"6","key":"10.1016\/j.sapharm.2024.04.010_bib47","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2006.01.007","article-title":"The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder","volume":"49","author":"Coyne","year":"2006","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.sapharm.2024.04.010_bib48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00451721","article-title":"Health-related quality of life measures for women with urinary incontinence: the incontinence impact Questionnaire and the urogenital distress inventory. Continence program in women (CPW) research group","volume":"3","author":"Shumaker","year":"1994","journal-title":"Qual Life Res"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124001244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124001244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T15:46:40Z","timestamp":1718466400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741124001244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1551741124001244"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.04.010","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of community pharmacy in the promotion of continence care: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}